UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.03 Million Stake in Phibro Animal Health Co. (NASDAQ:PAHC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 25.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 45,649 shares of the company’s stock after selling 15,608 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Phibro Animal Health were worth $1,028,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. BNP Paribas Financial Markets increased its stake in Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after acquiring an additional 729 shares during the period. Quantbot Technologies LP bought a new stake in Phibro Animal Health during the third quarter worth about $70,000. FMR LLC grew its stake in Phibro Animal Health by 22.7% during the third quarter. FMR LLC now owns 39,310 shares of the company’s stock worth $885,000 after buying an additional 7,270 shares in the last quarter. Algert Global LLC increased its holdings in Phibro Animal Health by 521.1% in the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after buying an additional 59,850 shares during the period. Finally, Segall Bryant & Hamill LLC raised its position in shares of Phibro Animal Health by 1.7% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company’s stock valued at $3,931,000 after buying an additional 2,971 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on PAHC shares. Bank of America increased their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. StockNews.com raised Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a report on Wednesday. Morgan Stanley raised their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday. Barclays lifted their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday, November 12th. Finally, JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Phibro Animal Health presently has an average rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Stock Performance

Shares of Phibro Animal Health stock opened at $21.27 on Thursday. The stock has a market cap of $861.50 million, a price-to-earnings ratio of 49.47, a P/E/G ratio of 0.58 and a beta of 0.51. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. Phibro Animal Health Co. has a twelve month low of $10.03 and a twelve month high of $25.98. The company’s fifty day moving average is $23.63 and its 200 day moving average is $20.66.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.26%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.